A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases
- PMID: 11267957
- DOI: 10.1002/1097-0142(20010315)91:6<1121::aid-cncr1108>3.0.co;2-2
A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases
Abstract
Background: Laparoscopy may identify occult metastatic disease and prevent unnecessary laparotomy in some patients with potentially resectable colorectal liver metastases but is unnecessary in the majority of individuals who undergo resection. The objectives of the current study were to assess the impact of laparoscopy after extensive preoperative imaging and to determine whether a preoperative clinical risk score can identify those patients most likely to benefit from the procedure.
Methods: Between December 1997 and July 1999, 103 consecutive patients with potentially resectable colorectal liver metastases underwent laparoscopy prior to planned laparotomy and partial hepatectomy. Surgical findings, length of hospital stay, and hospital charges were analyzed. Patients were assigned a clinical risk score (CRS) based on five factors related to the primary tumor and the hepatic disease. The likelihood of finding occult unresectable disease and the yield of laparoscopy were analyzed with respect to the CRS.
Results: Seventy-seven patients (75%) underwent resection. Laparoscopy identified 14 of 26 patients with unresectable disease, 10 of whom were spared an unnecessary laparotomy. In patients who underwent biopsy only, the laparoscopic identification of unresectable disease shortened the hospital stay (1.2 +/- 0.6 days vs. 5.8 +/- 2.3 days; p = 0.0001) and reduced the total hospital charges by 55% (P = 0.0001). The CRS predicted the likelihood of occult unresectable disease, which was 12% in those with a score < or = 2 but increased to 42% in those with a score > 2 (P = 0.001). If laparoscopy were used only in high risk patients (CRS > 2), 57 laparoscopies would have been avoided and the net savings doubled.
Conclusions: With extensive preoperative imaging, the vast majority of patients with potentially resectable hepatic colorectal metastases do not benefit from laparoscopy. However, in the minority of patients with occult unresectable disease, laparoscopy prevents unnecessary laparotomy and reduces hospital stay and the total hospital charges. The CRS, previously shown to predict survival after hepatic resection, identifies those high risk patients most likely to benefit from laparoscopy and may improve resource utilization.
Copyright 2001 American Cancer Society.
Similar articles
-
Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases.Arch Surg. 2004 Dec;139(12):1326-30. doi: 10.1001/archsurg.139.12.1326. Arch Surg. 2004. PMID: 15611458
-
The value of laparoscopic staging for patients with colorectal metastases.Arch Surg. 2003 Jul;138(7):770-2. doi: 10.1001/archsurg.138.7.770. Arch Surg. 2003. PMID: 12860759
-
Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease.J Am Coll Surg. 1999 Jan;188(1):33-42. doi: 10.1016/s1072-7515(98)00272-5. J Am Coll Surg. 1999. PMID: 9915240
-
[Diagnosis and treatment of colorectal liver metastases - workflow].Zentralbl Chir. 2008 Jun;133(3):267-84. doi: 10.1055/s-2008-1076796. Zentralbl Chir. 2008. PMID: 18563694 Review. German.
-
Surgical management of hepatic metastases of colorectal cancer.Hematol Oncol Clin North Am. 2015 Feb;29(1):61-84. doi: 10.1016/j.hoc.2014.09.003. Hematol Oncol Clin North Am. 2015. PMID: 25475573 Review.
Cited by
-
Laparoscopic resection of hepatic colorectal metastases.HPB (Oxford). 2004;6(4):230-5. doi: 10.1080/13651820410023978. HPB (Oxford). 2004. PMID: 18333080 Free PMC article.
-
Role of surgery in colorectal cancer liver metastases.World J Gastroenterol. 2014 May 28;20(20):6113-22. doi: 10.3748/wjg.v20.i20.6113. World J Gastroenterol. 2014. PMID: 24876733 Free PMC article. Review.
-
Laparoscopic staging for hepatobiliary carcinoma.J Gastrointest Surg. 2004 Dec;8(8):920-2. doi: 10.1016/j.gassur.2004.09.048. J Gastrointest Surg. 2004. PMID: 15702520 No abstract available.
-
Complex Surgical Strategies to Improve Resectability in Borderline-Resectable Disease.Curr Colorectal Cancer Rep. 2015 Dec;11(6):369-377. doi: 10.1007/s11888-015-0290-5. Epub 2015 Aug 18. Curr Colorectal Cancer Rep. 2015. PMID: 28090195 Free PMC article.
-
Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade.Ann Surg. 2002 Oct;236(4):397-406; discussion 406-7. doi: 10.1097/01.SLA.0000029003.66466.B3. Ann Surg. 2002. PMID: 12368667 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical